In this regard, the study by Sachpekidis et al. in 24 patients with primary therapy-naive PCa also showed only a weak correlation between GS and SUV parameters, though > 95% of patients had PSMA-positive PCa lesions [22]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.